COPENHAGEN, Denmark— Recent evidence supports repeated corneal cross-linking as an effective and safe option for patients with progressive ectasia following primary CXL failure.
Results from a study evaluating repeated CXL (re-CXL) conducted at the ELZA Institute in Zurich, Switzerland were presented by Michalina Depczynska, MD, MSc, at the European Society of Cataract and Refractive Surgeons meeting.
Although CXL remains the gold standard for halting progression in keratoconus and other ectatic disorders, failure — while uncommon — does occur.
“It has been reported in up to 14% of cases, and is